| “Delayed death” phenomenon: a synergistic action of cyclophosphamide and exogenous DNA EV Dolgova, AS Proskurina, VP Nikolin, NA Popova, EA Alyamkina, ... Gene 495 (2), 134-145, 2012 | 44 | 2012 |
| Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with … EV Dolgova, YR Efremov, KE Orishchenko, OM Andrushkevich, ... Gene 528 (2), 74-83, 2013 | 41 | 2013 |
| A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation EA Alyamkina, VP Nikolin, NA Popova, EV Dolgova, AS Proskurina, ... Genetic vaccines and therapy 8, 1-10, 2010 | 39 | 2010 |
| Effect of double-stranded DNA on maturation of dendritic cells in vitro EA Alyamkina, OY Leplina, LV Sakhno, ER Chernykh, AA Ostanin, ... Cellular Immunology 266 (1), 46-51, 2010 | 35 | 2010 |
| Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity EA Alyamkina, EV Dolgova, AS Likhacheva, VA Rogachev, TE Sebeleva, ... Cellular immunology 262 (2), 120-126, 2010 | 31 | 2010 |
| Future of human mitochondrial DNA editing technologies N Verechshagina, N Nikitchina, Y Yamada, Н Harashima, M Tanaka, ... Mitochondrial DNA Part A 30 (2), 214-221, 2019 | 28 | 2019 |
| Cell divisions are not essential for the direct conversion of fibroblasts into neuronal cells VS Fishman, TA Shnayder, KE Orishchenko, M Bader, N Alenina, ... Cell Cycle 14 (8), 1188-1196, 2015 | 27 | 2015 |
| Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice EA Alyamkina, OY Leplina, AA Ostanin, ER Chernykh, VP Nikolin, ... Cellular Immunology 276 (1-2), 59-66, 2012 | 24 | 2012 |
| Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice EA Alyamkina, EV Dolgova, AS Likhacheva, VA Rogachev, TE Sebeleva, ... Genetic Vaccines and Therapy 7, 1-11, 2009 | 24 | 2009 |
| Detection of mutations in mitochondrial DNA by droplet digital PCR JK Sofronova, YY Ilinsky, KE Orishchenko, EG Chupakhin, EA Lunev, ... Biochemistry (Moscow) 81 (10), 1031-1037, 2016 | 20 | 2016 |
| Nonadherent spheres with multiple myeloma surface markers contain cells that contribute to sphere formation and are capable of internalizing extracellular double-stranded DNA EV Dolgova, EY Shevela, TV Tyrinova, AM Minkevich, AS Proskurina, ... Clinical Lymphoma Myeloma and Leukemia 16 (10), 563-576, 2016 | 18 | 2016 |
| Effect of human double-stranded DNA preparation on the production of cytokines by dendritic cells and peripheral blood cells from relatively healthy donors KE Orishchenko, SL Ryzhikova, YG Druzhinina, TG Ryabicheva, ... Cancer Therapy 8, 191-205, 2013 | 12 | 2013 |
| Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen AS Proskurina, TS Gvozdeva, EA Potter, EV Dolgova, KE Orishchenko, ... BMC cancer 16, 1-9, 2016 | 11 | 2016 |
| Functional Evaluation of a Rare Variant c.516G>C (p.Trp172Cys) in the GJB2 (Connexin 26) Gene Associated with Nonsyndromic Hearing Loss EA Maslova, KE Orishchenko, OL Posukh Biomolecules 11 (1), 61, 2021 | 9 | 2021 |
| Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive … AS Proskurina, TS Gvozdeva, EA Alyamkina, EV Dolgova, ... BMC cancer 15, 1-17, 2015 | 9 | 2015 |
| Delivery Cas9 into mitochondria KE Orishchenko, JK Sofronova, EG Chupakhin, EA Lunev, IO Mazunin Genes & Cells 11 (2), 100-105, 2016 | 8 | 2016 |
| A Regulatory Potential of the Xist Gene Promoter in Vole M. rossiaemeridionalis KE Orishchenko, SV Pavlova, EA Elisaphenko, VV Sherstyuk, AV Prinz, ... PLoS One 7 (5), e33994, 2012 | 7 | 2012 |
| Targeted genomic integration of EGFP under tubulin beta 3 class III promoter and mEos2 under tryptophan hydroxylase 2 promoter does not produce sufficient levels of reporter … AG Menzorov, KE Orishchenko, VS Fishman, AA Shevtsova, ... Journal of Cellular Biochemistry 120 (10), 17208-17218, 2019 | 6 | 2019 |
| Evaluation of a strategy for tumor-initiating stem cell eradication in primary human glioblastoma cultures as a model EV Dolgova, AS Proskurina, EA Potter, TV Tyrinova, OS Taranov, ... Vavilov Journal of Genetics and Breeding 22 (7), 825-836, 2018 | 5 | 2018 |
| Study of hemostimulation activity of the nucleoprotein complex derived from human placenta VI Masycheva, ED Danilenko, GG Shimina, TS Gvozdeva, EA Alyamkina, ... Sibirskij onkologicheskij zhurnal, 34-38, 2012 | 5 | 2012 |
